Fig. 2From: Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysisRelationship between transplant modality and transplant outcomes for AML patients with pre-transplantation MRD who underwent allo-SCT (n = 141). Kaplan–Meier estimates of (a) cumulative incidence of relapse mortality, (b) cumulative incidence of non-relapse, (c) leukemia-free survival, and (d) overall survivalBack to article page